. The stock has been trending up for decades and for good reason: Johnson & Johnson’s business grows consistently through thick and thin.
Over the past 20 years, Johnson & Johnson’s adjusted earnings per share has grown at a steady 8% annually. And that means shareholders can look forward to higher dividends every year.That said, it’s not the highest yielder in the healthcare sector. Merck currently yields 3.5 per cent, Pfizer pays 3.6 per cent, while Novartis offers an even higher 3.9 per cent yield.
The company collects rent on these properties and passes it along to shareholders in the form of dividends. The stock is currently offering a handsome 4.8 per cent yield. Store’s tenants tend to be leading national and regional companies with large revenue bases. And because Store’s portfolio is leased to 529 tenants coming from 118 different industries, the REIT can maintain its dividend even if one tenant or industry enters a downturn. That makes it an interesting pick for